Position in ABSI
as of Jun 30, 2026
· filed Sep 9, 2026
Position Value
$3,106
New position
Shares Held
268
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Core Capital Management & Research, inc. holds $12,361 across 2 Biotechnology names. ABSI ranks #2 (25.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FENC |
Fennec Pharmaceuticals Inc.
|
861 | $9,255 | |
| 2 | ABSI |
Absci Corp
This page
|
268 | $3,106 |
All Filings in ABSI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,106 | 268 | Shares | Sole | 2026-09-09 | |
| No filing history on record for this holder in this stock. | ||||||